NYSE:NHI - National Health Investors Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$78.80 +0.20 (+0.25 %)
(As of 01/18/2019 09:07 AM ET)
Previous Close$78.60
Today's Range$78.32 - $79.12
52-Week Range$62.71 - $81.56
Volume125,544 shs
Average Volume200,242 shs
Market Capitalization$3.32 billion
P/E Ratio14.78
Dividend Yield5.09%
Beta0.35
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Receive NHI News and Ratings via Email

Sign-up to receive the latest news and ratings for NHI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustrySpecialized REITs
SectorFinance
CUSIP63633D10
Phone615-890-9100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$278.66 million
Cash Flow$5.6006 per share
Book Value$31.83 per share

Profitability

Net Income$159.36 million

Miscellaneous

EmployeesN/A
Market Cap$3.32 billion
OptionableOptionable

National Health Investors (NYSE:NHI) Frequently Asked Questions

What is National Health Investors' stock symbol?

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors?

National Health Investors declared a quarterly dividend on Tuesday, December 18th. Investors of record on Monday, December 31st will be given a dividend of $1.00 per share on Thursday, January 31st. This represents a $4.00 dividend on an annualized basis and a yield of 5.08%. The ex-dividend date of this dividend is Friday, December 28th. View National Health Investors' Dividend History.

How were National Health Investors' earnings last quarter?

National Health Investors Inc (NYSE:NHI) issued its earnings results on Tuesday, November, 6th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.39 by $0.42. The real estate investment trust had revenue of $74.92 million for the quarter, compared to the consensus estimate of $73.72 million. National Health Investors had a net margin of 53.15% and a return on equity of 11.56%. National Health Investors's revenue was up 5.0% compared to the same quarter last year. During the same period in the prior year, the business earned $1.37 EPS. View National Health Investors' Earnings History.

When is National Health Investors' next earnings date?

National Health Investors is scheduled to release their next quarterly earnings announcement on Friday, February 15th 2019. View Earnings Estimates for National Health Investors.

What guidance has National Health Investors issued on next quarter's earnings?

National Health Investors updated its FY 2018 earnings guidance on Tuesday, November, 6th. The company provided earnings per share (EPS) guidance of $3.73-3.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.75. National Health Investors also updated its FY18 guidance to $5.47-5.51 EPS.

What price target have analysts set for NHI?

9 brokerages have issued 1-year target prices for National Health Investors' shares. Their forecasts range from $65.00 to $83.00. On average, they expect National Health Investors' stock price to reach $74.5714 in the next year. This suggests that the stock has a possible downside of 5.4%. View Analyst Price Targets for National Health Investors.

What is the consensus analysts' recommendation for National Health Investors?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 1 sell rating, 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for National Health Investors.

What are Wall Street analysts saying about National Health Investors stock?

Here are some recent quotes from research analysts about National Health Investors stock:
  • 1. According to Zacks Investment Research, "National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. " (1/16/2019)
  • 2. Cantor Fitzgerald analysts commented, ". We are lowering our 2019 outlook slightly, to reflect NHI’s amended lease with Holiday, but reiterating our $80 price target and Neutral rating. NHI reported in-line 3Q18 results and reaffirmed its full year 2018 guidance, but announced a lease amendment with Holiday (which accounts for 14% of revenue) that will cut the operator’s rent in 2019. M&A was limited, but NHI continued to fund $56 million of development/redevelopment commitments. The company’s relatively low leverage and strong lease coverage, despite Holiday’s issues, reflect NHI’s balance, and its primary reliance upon deal-making with its existing operators." (11/8/2018)

Has National Health Investors been receiving favorable news coverage?

Media coverage about NHI stock has been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. National Health Investors earned a media sentiment score of 0.7 on InfoTrie's scale. They also gave news coverage about the real estate investment trust a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days.

Who are some of National Health Investors' key competitors?

Who are National Health Investors' key executives?

National Health Investors' management team includes the folowing people:
  • Mr. D. Eric Mendelsohn, Pres & CEO (Age 56)
  • Mr. John L. Spaid, Exec. VP of Fin. (Age 58)
  • Mr. Kevin Carlton Pascoe, Chief Investment Officer (Age 37)
  • Mr. Roger R. Hopkins, Chief Accounting Officer (Age 56)
  • Ms. Colleen Schaller, Director, Investor Relations

Who are National Health Investors' major shareholders?

National Health Investors' stock is owned by a number of of retail and institutional investors. Top institutional investors include Nisa Investment Advisors LLC (0.04%), State of Alaska Department of Revenue (0.03%), Navellier & Associates Inc (0.01%), Carroll Financial Associates Inc. (0.00%) and Meeder Asset Management Inc. (0.00%). Company insiders that own National Health Investors stock include D Eric Mendelsohn, John L Spaid, Kevin Carlton Pascoe, Kristin Sallee Gaines and Robert A Mccabe Jr. View Institutional Ownership Trends for National Health Investors.

Which major investors are selling National Health Investors stock?

NHI stock was sold by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC, Meeder Asset Management Inc. and Carroll Financial Associates Inc.. Company insiders that have sold National Health Investors company stock in the last year include Kevin Carlton Pascoe, Kristin Sallee Gaines and Robert A Mccabe Jr. View Insider Buying and Selling for National Health Investors.

Which major investors are buying National Health Investors stock?

NHI stock was acquired by a variety of institutional investors in the last quarter, including Navellier & Associates Inc and State of Alaska Department of Revenue. Company insiders that have bought National Health Investors stock in the last two years include D Eric Mendelsohn, John L Spaid and Robert A Mccabe Jr. View Insider Buying and Selling for National Health Investors.

How do I buy shares of National Health Investors?

Shares of NHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is National Health Investors' stock price today?

One share of NHI stock can currently be purchased for approximately $78.80.

How big of a company is National Health Investors?

National Health Investors has a market capitalization of $3.32 billion and generates $278.66 million in revenue each year. The real estate investment trust earns $159.36 million in net income (profit) each year or $5.33 on an earnings per share basis.

What is National Health Investors' official website?

The official website for National Health Investors is http://www.nhireit.com.

How can I contact National Health Investors?

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust can be reached via phone at 615-890-9100 or via email at [email protected]


MarketBeat Community Rating for National Health Investors (NYSE NHI)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  256 (Vote Outperform)
Underperform Votes:  318 (Vote Underperform)
Total Votes:  574
MarketBeat's community ratings are surveys of what our community members think about National Health Investors and other stocks. Vote "Outperform" if you believe NHI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NHI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2019 by MarketBeat.com Staff

Featured Article: What is a balanced fund?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel